CHM chimeric therapeutics limited

Ann: ADVENT-AML Phase 1B clinical trial update, page-68

  1. 4,386 Posts.
    lightbulb Created with Sketch. 4553
    Merely attempting to gauge efficacy against SOC treatments.

    This should interest you:

    https://www.nejm.org/doi/full/10.1056/NEJMoa2012971

    https://hotcopper.com.au/data/attachments/7003/7003363-91f89a27a4143aca7bd60aa2299f5aac.jpg
    https://hotcopper.com.au/data/attachments/7003/7003366-4a03e0f0736e6166289ed5b2b067e3ae.jpg
    https://hotcopper.com.au/data/attachments/7003/7003368-1d04fab51cc5d0c4bb64449060142894.jpg


    Obviously very early days but no improvement to the expected response rate in this patient demographic.

    https://hotcopper.com.au/data/attachments/7003/7003369-28de0c0ea9904fa25789486b3212abb8.jpg

    Very odd statement here too... why "however"? Not expecting 20 patients?

    https://hotcopper.com.au/data/attachments/7003/7003372-3227f5e3d42603d8f278f8b1fecb3062.jpg


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $15.69K 3.919M

Buyers (Bids)

No. Vol. Price($)
26 21936206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 24685267 27
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.